Similar articles for PMID: 26289226

Year	Number of Results
1995	1
1996	2
2000	1
2003	3
2005	3
2006	3
2007	5
2008	3
2009	5
2010	4
2011	3
2012	5
2013	10
2014	4
2015	10
2016	12
2017	15
2018	10
2019	12
2020	21
2021	20
2022	19
2023	6
2024	0

1

Key findings from studies of methotrexate tapering and withdrawal in rheumatoid arthritis.

Subesinghe S, Scott IC. Subesinghe S, et al. Expert Rev Clin Pharmacol. 2015;8(6):751-60. doi: 10.1586/17512433.2015.1077698. Epub 2015 Aug 13. Expert Rev Clin Pharmacol. 2015. PMID: 26289226 Review.

2

Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial.

Kuijper TM, Luime JJ, de Jong PH, Gerards AH, van Zeben D, Tchetverikov I, de Sonnaville PB, van Krugten MV, Grillet BA, Hazes JM, Weel AE. Kuijper TM, et al. Ann Rheum Dis. 2016 Dec;75(12):2119-2123. doi: 10.1136/annrheumdis-2016-209272. Epub 2016 Jun 9. Ann Rheum Dis. 2016. PMID: 27283332 Clinical Trial.

3

Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial.

Lillegraven S, Paulshus Sundlisæter N, Aga AB, Sexton J, Olsen IC, Fremstad H, Spada C, Madland TM, Høili CA, Bakland G, Lexberg Å, Hansen IJW, Hansen IM, Haukeland H, Ljoså MA, Moholt E, Uhlig T, Solomon DH, van der Heijde D, Kvien TK, Haavardsholm EA. Lillegraven S, et al. JAMA. 2021 May 4;325(17):1755-1764. doi: 10.1001/jama.2021.4542. JAMA. 2021. PMID: 33944875 Free PMC article. Clinical Trial.

4

Effectiveness, safety, and methotrexate dose-tapering pattern over two years of treatment with adalimumab and ≥12 mg/week methotrexate for early rheumatoid arthritis: Results of the HAWK postmarketing surveillance study in Japan.

Tanaka Y, Mimori T, Yamanaka H, Sunaga N, Morita K, Kimura J, Takeuchi T. Tanaka Y, et al. Mod Rheumatol. 2020 May;30(3):424-433. doi: 10.1080/14397595.2019.1639931. Epub 2019 Jul 22. Mod Rheumatol. 2020. PMID: 31267801 Clinical Trial.

5

The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.

Tanaka Y, Smolen JS, Jones H, Szumski A, Marshall L, Emery P. Tanaka Y, et al. Arthritis Res Ther. 2019 Jul 5;21(1):164. doi: 10.1186/s13075-019-1937-4. Arthritis Res Ther. 2019. PMID: 31277720 Free PMC article.

6

Meta-Regression of a Dose-Response Relationship of Methotrexate in Mono- and Combination Therapy in Disease-Modifying Antirheumatic Drug-Naive Early Rheumatoid Arthritis Patients.

Bergstra SA, Allaart CF, Stijnen T, Landewé RBM. Bergstra SA, et al. Arthritis Care Res (Hoboken). 2017 Oct;69(10):1473-1483. doi: 10.1002/acr.23164. Epub 2017 Aug 31. Arthritis Care Res (Hoboken). 2017. PMID: 27992656 Review.

7

Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.

Singh JA, Hossain A, Mudano AS, Tanjong Ghogomu E, Suarez-Almazor ME, Buchbinder R, Maxwell LJ, Tugwell P, Wells GA. Singh JA, et al. Cochrane Database Syst Rev. 2017 May 8;5(5):CD012657. doi: 10.1002/14651858.CD012657. Cochrane Database Syst Rev. 2017. PMID: 28481462 Free PMC article. Review.

8

Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis.

Cummins L, Katikireddi VS, Shankaranarayana S, Su KY, Duggan E, Videm V, Pahau H, Thomas R. Cummins L, et al. Intern Med J. 2015 Dec;45(12):1266-73. doi: 10.1111/imj.12896. Intern Med J. 2015. PMID: 26384029

9

Flare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review.

Kuijper TM, Lamers-Karnebeek FB, Jacobs JW, Hazes JM, Luime JJ. Kuijper TM, et al. J Rheumatol. 2015 Nov;42(11):2012-22. doi: 10.3899/jrheum.141520. Epub 2015 Oct 1. J Rheumatol. 2015. PMID: 26428204 Review.

10

Dose tapering of biologic agents in patients with rheumatoid arthritis-results from a cohort study in Germany.

Krause D, Krause C, Rudolf H, Baraliakos X, Braun J, Schmitz E. Krause D, et al. Clin Rheumatol. 2021 Mar;40(3):887-893. doi: 10.1007/s10067-020-05316-9. Epub 2020 Aug 21. Clin Rheumatol. 2021. PMID: 32822057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

155 results

Results by year